Synopsis
Synopsis
0
JDMF
0
EU WC
0
VMF
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Chloride, Morphine
2. Contin, Ms
3. Duramorph
4. Morphia
5. Morphine
6. Morphine Chloride
7. Morphine Sulfate
8. Morphine Sulfate (2:1), Anhydrous
9. Morphine Sulfate (2:1), Pentahydrate
10. Ms Contin
11. Oramorph Sr
12. Sdz 202 250
13. Sdz 202-250
14. Sdz 202250
15. Sdz202 250
16. Sdz202-250
17. Sdz202250
18. Sulfate, Morphine
1. Morphine Sulfate
2. Schembl29317
3. Morphinesulfatenarcoticanalgesic
Molecular Weight | 383.4 g/mol |
---|---|
Molecular Formula | C17H21NO7S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 0 |
Exact Mass | 383.10387318 g/mol |
Monoisotopic Mass | 383.10387318 g/mol |
Topological Polar Surface Area | 136 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 576 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Astramorph pf |
PubMed Health | Morphine (Injection) |
Active Ingredient | Morphine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml; 0.5mg/ml |
Market Status | Prescription |
Company | Fresenius Kabi Usa |
2 of 6 | |
---|---|
Drug Name | Duramorph pf |
Active Ingredient | Morphine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml; 0.5mg/ml |
Market Status | Prescription |
Company | Hikma Maple |
3 of 6 | |
---|---|
Drug Name | Morphine sulfate |
PubMed Health | Morphine Sulfate Liposome (Injection) |
Drug Classes | Analgesic, Anesthetic Adjunct, Central Nervous System Agent |
Drug Label | DESCRIPTIONChemically, morphine sulfate is 7, 8-didehydro-4, 5-epoxy-17-methylmorphinan-3, 6-diol sulfate (2:1) (salt) pentahydrate... |
Active Ingredient | Morphine sulfate |
Dosage Form | Tablet, extended release; Tablet; Injectable; Capsule, extended release; Solution |
Route | Intramuscular, intravenous; oral; Injection; Oral |
Strength | 2mg/ml; 200mg; 10mg/5ml; 1mg/ml; 8mg/ml (8mg/ml); 30mg; 10mg/ml (10mg/ml); 100mg/5ml; 90mg; 15mg; 120mg; 4mg/ml (4mg/ml); 10mg/ml; 0.5mg/ml; 2mg/ml (2mg/ml); 75mg; 4mg/ml; 5mg/ml; 100mg; 5mg/ml (5mg/ml); 8mg/ml; 50mg; 60mg; 10mg; 15mg/ml; 20mg/5ml; 80mg; |
Market Status | Prescription |
Company | Clonmel Hlthcare; Vintage Pharms; Mylan Pharms; Upsher Smith; Hospira; Mallinckrodt; Rhodes Pharms; Meridian Medcl; Par Pharm; Roxane; Lannett Holdings; Nesher Pharms; Vistapharm; Actavis Elizabeth; Paddock; Caraco; Ranbaxy Labs; Bd Rx |
4 of 6 | |
---|---|
Drug Name | Astramorph pf |
PubMed Health | Morphine (Injection) |
Active Ingredient | Morphine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml; 0.5mg/ml |
Market Status | Prescription |
Company | Fresenius Kabi Usa |
5 of 6 | |
---|---|
Drug Name | Duramorph pf |
Active Ingredient | Morphine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml; 0.5mg/ml |
Market Status | Prescription |
Company | Hikma Maple |
6 of 6 | |
---|---|
Drug Name | Morphine sulfate |
PubMed Health | Morphine Sulfate Liposome (Injection) |
Drug Classes | Analgesic, Anesthetic Adjunct, Central Nervous System Agent |
Drug Label | DESCRIPTIONChemically, morphine sulfate is 7, 8-didehydro-4, 5-epoxy-17-methylmorphinan-3, 6-diol sulfate (2:1) (salt) pentahydrate... |
Active Ingredient | Morphine sulfate |
Dosage Form | Tablet, extended release; Tablet; Injectable; Capsule, extended release; Solution |
Route | Intramuscular, intravenous; oral; Injection; Oral |
Strength | 2mg/ml; 200mg; 10mg/5ml; 1mg/ml; 8mg/ml (8mg/ml); 30mg; 10mg/ml (10mg/ml); 100mg/5ml; 90mg; 15mg; 120mg; 4mg/ml (4mg/ml); 10mg/ml; 0.5mg/ml; 2mg/ml (2mg/ml); 75mg; 4mg/ml; 5mg/ml; 100mg; 5mg/ml (5mg/ml); 8mg/ml; 50mg; 60mg; 10mg; 15mg/ml; 20mg/5ml; 80mg; |
Market Status | Prescription |
Company | Clonmel Hlthcare; Vintage Pharms; Mylan Pharms; Upsher Smith; Hospira; Mallinckrodt; Rhodes Pharms; Meridian Medcl; Par Pharm; Roxane; Lannett Holdings; Nesher Pharms; Vistapharm; Actavis Elizabeth; Paddock; Caraco; Ranbaxy Labs; Bd Rx |
Analgesics, Opioid
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)
Narcotics
Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
29
PharmaCompass offers a list of Morphine Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Morphine Sulfate manufacturer or Morphine Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Morphine Sulfate manufacturer or Morphine Sulfate supplier.
PharmaCompass also assists you with knowing the Morphine Sulfate API Price utilized in the formulation of products. Morphine Sulfate API Price is not always fixed or binding as the Morphine Sulfate Price is obtained through a variety of data sources. The Morphine Sulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Astramorph PF manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Astramorph PF, including repackagers and relabelers. The FDA regulates Astramorph PF manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Astramorph PF API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Astramorph PF manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Astramorph PF supplier is an individual or a company that provides Astramorph PF active pharmaceutical ingredient (API) or Astramorph PF finished formulations upon request. The Astramorph PF suppliers may include Astramorph PF API manufacturers, exporters, distributors and traders.
click here to find a list of Astramorph PF suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Astramorph PF DMF (Drug Master File) is a document detailing the whole manufacturing process of Astramorph PF active pharmaceutical ingredient (API) in detail. Different forms of Astramorph PF DMFs exist exist since differing nations have different regulations, such as Astramorph PF USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Astramorph PF DMF submitted to regulatory agencies in the US is known as a USDMF. Astramorph PF USDMF includes data on Astramorph PF's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Astramorph PF USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Astramorph PF suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Astramorph PF Drug Master File in Korea (Astramorph PF KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Astramorph PF. The MFDS reviews the Astramorph PF KDMF as part of the drug registration process and uses the information provided in the Astramorph PF KDMF to evaluate the safety and efficacy of the drug.
After submitting a Astramorph PF KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Astramorph PF API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Astramorph PF suppliers with KDMF on PharmaCompass.
A Astramorph PF CEP of the European Pharmacopoeia monograph is often referred to as a Astramorph PF Certificate of Suitability (COS). The purpose of a Astramorph PF CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Astramorph PF EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Astramorph PF to their clients by showing that a Astramorph PF CEP has been issued for it. The manufacturer submits a Astramorph PF CEP (COS) as part of the market authorization procedure, and it takes on the role of a Astramorph PF CEP holder for the record. Additionally, the data presented in the Astramorph PF CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Astramorph PF DMF.
A Astramorph PF CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Astramorph PF CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Astramorph PF suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Astramorph PF as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Astramorph PF API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Astramorph PF as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Astramorph PF and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Astramorph PF NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Astramorph PF suppliers with NDC on PharmaCompass.
Astramorph PF Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Astramorph PF GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Astramorph PF GMP manufacturer or Astramorph PF GMP API supplier for your needs.
A Astramorph PF CoA (Certificate of Analysis) is a formal document that attests to Astramorph PF's compliance with Astramorph PF specifications and serves as a tool for batch-level quality control.
Astramorph PF CoA mostly includes findings from lab analyses of a specific batch. For each Astramorph PF CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Astramorph PF may be tested according to a variety of international standards, such as European Pharmacopoeia (Astramorph PF EP), Astramorph PF JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Astramorph PF USP).